SAR exploration of the non-imidazole histamine H3 receptor ligand ZEL-H16 reveals potent inverse agonism.
Wágner G, Mocking TAM, Ma X, Slynko I, Da Costa Pereira D, Breeuwer R, Rood NJN, van der Horst C, Vischer HF, de Graaf C, de Esch IJP, Wijtmans M, Leurs R.
Wágner G, et al. Among authors: ma x.
Arch Pharm (Weinheim). 2023 Jan;356(1):e2200451. doi: 10.1002/ardp.202200451. Epub 2022 Oct 30.
Arch Pharm (Weinheim). 2023.
PMID: 36310109